Helena W. Rodbard - Articles and news items

Novo Nordisk Logo

Investigational insulin degludec shows 43% lower rates of night-time hypoglycaemia

Industry news, News / 2 October 2012 / Novo Nordisk

Than insulin glargine in a 2-year study investigating people with type 2 diabetes…

Merck logo

FDA approves Merck’s JUVISYNC™ (sitagliptin and simvastatin) tablets

Industry news / 7 October 2011 / Merck

Multiple national guidelines recommend that patients with type 2 diabetes be treated for cholesterol…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+